Market Cap 1.86B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 4,619,800
Avg Vol 6,655,782
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 76%
Beta 1.20
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon Aug. 6 at 3:20 PM
$ABCL $ABCL received three bullish analyst updates after earnings: • Cantor reiterated Overweight and raised its target from $11 to $12 • Stifel maintained Buy and raised its target from $8 to $9 • TD Cowen maintained Buy Nice to see, but i feel like these numbers are bearish we are going to 20 after all 🤷‍♂️😂
0 · Reply
BruceyMatt
BruceyMatt Aug. 6 at 3:19 PM
$ABCL @tradersunion353 hope you added and loaded during that latest dip like the rest of us maggot pumpers
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 6 at 3:18 PM
$ABCL $ABCL That dip was short lived 🤣 LFG!!!
0 · Reply
MariaLaPaz
MariaLaPaz Aug. 6 at 3:09 PM
$ABCL Sorry my ignorance, can someone with knowledge tell us if this stock has the ingredients for a short squeeze? Or no (too many shares, short % too low... etc etc?)
3 · Reply
Ckkung71
Ckkung71 Aug. 6 at 3:06 PM
$ABCL Fore ones if they shorters baying back don’t be satisfied which a penny trade🙏
0 · Reply
Stockingtrade
Stockingtrade Aug. 6 at 2:59 PM
$ABCL Starting to look a lot like the June 24 start of the wave. How high will this wave take us?? If the last one went to $8, will this be $10? $12?? And if the readouts are good, $20??
1 · Reply
Targhee
Targhee Aug. 6 at 2:57 PM
0 · Reply
DeMampCamp
DeMampCamp Aug. 6 at 2:55 PM
$ABCL Hey bears.....
0 · Reply
The_Blunderer
The_Blunderer Aug. 6 at 2:50 PM
$ABCL Welcome back. I mssed you so much.
0 · Reply
tradersunion353
tradersunion353 Aug. 6 at 2:45 PM
$ABCL pos when will you start rewarding investors???? you can announce 100 good things but real investors need to rewarded can you just jump to $12 already enough of company and ceo drama for last several years
1 · Reply
Latest News on ABCL
AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 3 hours ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 18 hours ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 18 hours ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 18 hours ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 18 hours ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 19 hours ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 4 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 4 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 4 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 2 months ago

AbCellera appoints Victor Sandor to board of directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 3 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 3 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 4 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


Stocktradesmoon
Stocktradesmoon Aug. 6 at 3:20 PM
$ABCL $ABCL received three bullish analyst updates after earnings: • Cantor reiterated Overweight and raised its target from $11 to $12 • Stifel maintained Buy and raised its target from $8 to $9 • TD Cowen maintained Buy Nice to see, but i feel like these numbers are bearish we are going to 20 after all 🤷‍♂️😂
0 · Reply
BruceyMatt
BruceyMatt Aug. 6 at 3:19 PM
$ABCL @tradersunion353 hope you added and loaded during that latest dip like the rest of us maggot pumpers
0 · Reply
Stocktradesmoon
Stocktradesmoon Aug. 6 at 3:18 PM
$ABCL $ABCL That dip was short lived 🤣 LFG!!!
0 · Reply
MariaLaPaz
MariaLaPaz Aug. 6 at 3:09 PM
$ABCL Sorry my ignorance, can someone with knowledge tell us if this stock has the ingredients for a short squeeze? Or no (too many shares, short % too low... etc etc?)
3 · Reply
Ckkung71
Ckkung71 Aug. 6 at 3:06 PM
$ABCL Fore ones if they shorters baying back don’t be satisfied which a penny trade🙏
0 · Reply
Stockingtrade
Stockingtrade Aug. 6 at 2:59 PM
$ABCL Starting to look a lot like the June 24 start of the wave. How high will this wave take us?? If the last one went to $8, will this be $10? $12?? And if the readouts are good, $20??
1 · Reply
Targhee
Targhee Aug. 6 at 2:57 PM
0 · Reply
DeMampCamp
DeMampCamp Aug. 6 at 2:55 PM
$ABCL Hey bears.....
0 · Reply
The_Blunderer
The_Blunderer Aug. 6 at 2:50 PM
$ABCL Welcome back. I mssed you so much.
0 · Reply
tradersunion353
tradersunion353 Aug. 6 at 2:45 PM
$ABCL pos when will you start rewarding investors???? you can announce 100 good things but real investors need to rewarded can you just jump to $12 already enough of company and ceo drama for last several years
1 · Reply
Drewz93
Drewz93 Aug. 6 at 2:41 PM
the sun is shining $ABCL is green and @tradersunion353 is somewhere playing tummy sticks. Good day gents!
0 · Reply
tiddyy
tiddyy Aug. 6 at 2:40 PM
$ABCL This will be the future
0 · Reply
Stockingtrade
Stockingtrade Aug. 6 at 2:35 PM
$ABCL Voluuuuume!! 2m+ in first hour of trading. Looks a lot like it did at the start of the wave in June!
0 · Reply
Vogelito
Vogelito Aug. 6 at 2:21 PM
$ABCL anyone heard or seen of @tradersunion353 ?
4 · Reply
The_Blunderer
The_Blunderer Aug. 6 at 2:16 PM
$ABCL the price action is so unpredictable right now
2 · Reply
Buying_Low_Selling_High
Buying_Low_Selling_High Aug. 6 at 2:10 PM
$ABCL 500K+ share sale is again the attempt to move it down. It got digested pretty fast. August data readout is key.
0 · Reply
Stockingtrade
Stockingtrade Aug. 6 at 1:54 PM
$ABCL 3 analysts maintained buy rating, with 2 upgrading their targets (to $9 and $11). They’re seeing the writing on the wall for the readouts - literally all of them have “buy” ratings!
1 · Reply
Stockingtrade
Stockingtrade Aug. 6 at 1:51 PM
$ABCL Readout in a couple weeks - how high will the stock go the day after the news release, if it’s positive?
1 · Reply
Biker68
Biker68 Aug. 6 at 1:40 PM
$ABCL I don't get this reaction, but I'm happy, and relieved! 😀
1 · Reply
Plutten1973
Plutten1973 Aug. 6 at 1:38 PM
$ABCL Wtf first time we go up after earnings
3 · Reply
Planetpaprika
Planetpaprika Aug. 6 at 1:26 PM
$ABCL CFO A. Booth: “AbCellera continues to be in a strong liquidity position with over $565 million in cash and equivalents and with roughly $110 million in available committed government funding” CEO Hansen said re the business development: 2 new T cell engager partnerships “are adding over $110 million in upfront cash to our balance sheet. “Under the terms of the deal, AbCellera will receive $28 million in upfront payments” from Vertex, and the Jazz collaboration includes “3 confirmed discovery programs with $84 million in total near-term upfront payments” and eligibility “to receive over $2 billion in potential downstream payments… The total potential deal value with all 5 programs included would be over $4 billion.” The board added 2 independent directors: Dr. Victor Stander & Dr. Lynn Sealy as new Independent Directors on AbCellera’s Board.
0 · Reply
Planetpaprika
Planetpaprika Aug. 6 at 1:22 PM
$ABCL ´s CEO “The most important data readout this year is the top line results for ABCL635 in the treatment of moderate to severe hot flashes associated with menopause. Completed enrollment & initial dosing of patients in June, well ahead of schedule, expect a top line data readout very soon.” If ABCL635 data are positive,we’ve been preparing for next steps, which would incl. late-stage clinical development+clinical studies to evaluate ABCL635 in treating VMS associated with cancer treatment. ABCL-688 + ABCL386 continue to progress through IND-enabling activities. We expect both to enter Phase I/II studies in 2027. ABCL575 completed dosing, on track for a readout in Q4. We currently have no plans to develop it past PH I. Re a timing slip on discovery expansion: “I had previously communicated a goal of moving another program into IND-enabling activities in the 1st half of this year. Although we missed this time line. I’m confident in the productivity+innovation of discovery.”
0 · Reply